Gefarnate
From Infogalactic: the planetary knowledge core
Skeletal formula | |
Space-filling model | |
Systematic (IUPAC) name | |
---|---|
(2E)-3,7-dimethylocta-2,6-dien-1-yl (4E,8E)-5,9,13-trimethyltetradeca-4,8,12-trienoate
|
|
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Identifiers | |
CAS Number | 51-77-4 |
ATC code | A02BX07 (WHO) |
PubChem | CID: 5282182 |
ChemSpider | 4445377 |
UNII | 1ISE2Y6ULA |
KEGG | D01529 |
ChEMBL | CHEMBL2105085 |
Chemical data | |
Formula | C27H44O2 |
Molecular mass | 400.637 g/mol |
|
|
|
|
(what is this?) (verify) |
Gefarnate is a drug used for the treatment of gastric ulcers.[1]
It also has been proposed for use in the treatment of dry eye syndrome.[2][3]
References
<templatestyles src="Asbox/styles.css"></templatestyles>
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Pages with broken file links
- Chemical articles having calculated molecular weight overwritten
- Articles with changed InChI identifier
- Infobox drug articles without a structure image
- Chemical pages without DrugBank identifier
- Drugs with no legal status
- Drugs acting on the gastrointestinal system and metabolism
- Carboxylate esters
- Polyolefins
- Alkene stubs
- Gastrointestinal system drug stubs